Table 3.
Overall survival | Disease-free survival | |||
---|---|---|---|---|
Variables | HR (95%CI) | P | HR (95%CI) | P |
Location | ||||
Upper/Middle | 1 (reference) | 1 (reference) | ||
Lower/EGJ | 0.254 (0.104-0.619) | 0.003 | 0.326 (0.148-0.720) | 0.006 |
Tumor length | ||||
≥ 5 cm vs.<5cm | 3.900 (1.362-11.166) | 0.011 | 0.098 | |
Chemotherapy | ||||
Yes vs. No | 0.487 (0.247-0.960) | 0.038 | 0.177 | |
pN category | ||||
N+ vs. N0 | 2.344 (1.162-4.731) | 0.017 | 2.766 (1.411-5.422) | 0.003 |
pT category | 0.593 | 0.168 | ||
Gender | 0.309 | 0.911 | ||
Age | 0.565 | 0.238 | ||
BMI | 0.224 | 0.663 | ||
Chronic diseases | 0.886 | 0.561 | ||
Preoperative albumin level | 0.685 | 0.681 | ||
Surgical approach | 0.729 | 0.724 | ||
Pathological features | 0.369 | 0.203 | ||
Radiotherapy | 0.544 | 0.518 |
Abbreviations: HR, hazard ratio; 95%CI, 95% confidence interval; vs, versus; EGJ, esophagogastric junction; BMI, body mass index.
a Bold values refer to a significant difference.